Immune regulation and the eye

Trends in Immunology

Volumn 29, Issue 11, 2008, Pages 548-554

  Stein Streilein, Joan ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CELL MARKER; CELL RECEPTOR; F4 80 PROTEIN; FAS LIGAND; LY49 RECEPTOR PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ANTERIOR EYE CHAMBER IMMUNE DEVIATION; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; EYE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INTESTINE; NATURAL KILLER T CELL; NONHUMAN; REVIEW;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; EYE; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; T-LYMPHOCYTES;

EID: 53849128828     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.08.002     Document Type: Review

References (88)

1. Coster D.J., and Williams K.A. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am. J. Ophthalmol. 140 (2005) 1112-1122
2. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3 (2003) 878-889
3. Sonoda K.H., et al. The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation. Immunology 116 (2005) 390-399
4. Jiang L.Q., et al. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest. Ophthalmol. Vis. Sci. 34 (1993) 3347-3354
5. Hori J., et al. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule. Invest. Ophthalmol. Vis. Sci. 41 (2000) 443-452
6. Hori J., et al. Immune privilege and immunogenicity reside among different layers of the mouse cornea. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3032-3042
7. Stein-Streilein J., and Taylor A.W. An eye's view of T regulatory cells. J. Leukoc. Biol. 81 (2007) 593-598
8. Taylor A.W. Ocular immunosuppressive microenvironment. Chem. Immunol. Allergy 92 (2007) 71-85
9. Goslings W.R.O., et al. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest. Ophthalmol. Vis. Sci. 39 (1998) 989-995
10. Apte R.S., et al. Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J. Immunol. 160 (1998) 5693-5696
11. Sugita S., et al. Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta. Exp. Eye Res. 83 (2006) 1459-1471
12. Sugita S., et al. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. Invest. Ophthalmol. Vis. Sci. 47 (2006) 5376-5384
13. Sugita S., et al. B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells. J. Immunol. 176 (2006) 118-127
14. Sugita S., and Streilein J.W. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 198 (2003) 161-171
15. Sugita S., et al. CTLA-4+ CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. J. Immunol. 172 (2004) 4184-4194
16. Zamiri P., et al. Thrombospondin plays a vital role in the immune privilege of the eye. Invest. Ophthalmol. Vis. Sci. 46 (2005) 908-919
17. Griffith T.S., et al. CD95-induced apoptois of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5 (1997) 7-16
18. Hori J., et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 177 (2006) 5928-5935
19. Griffith T.S., et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 (1995) 1189-1192
20. Ferguson T.A., and Griffith T.S. The role of Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL) in the ocular immune response. Chem. Immunol. Allergy 92 (2007) 140-154
21. Ferguson T.A., et al. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness. J. Immunol. 168 (2002) 5589-5595
22. Kaplan H.J., et al. Transplantation immunology of the anterior chamber of the eye. II. Immune response to allogeneic cells. J. Immunol. 115 (1975) 805-810
23. Niederkorn J.Y. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7 (2006) 354-359
24. Wang Y., et al. Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation. J. Leukoc. Biol. 69 (2001) 741-746
25. Li X., et al. Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies. Immunology 113 (2004) 44-56
26. Li X., et al. Phenotypic and immunoregulatory characteristics of monocytic iris cells. Immunology 117 (2006) 566-575
27. Faunce D.E., et al. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166 (2001) 313-321
28. Faunce D.E., and Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J. Immunol. 169 (2002) 31-38
29. Zhang-Hoover J., et al. Modulation of ovalbumin-induced airway inflammation and hyperreactivity by tolerogenic APC. J. Immunol. 175 (2005) 7117-7124
30. D'Orazio T.J., and Niederkorn J.Y. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J. Immunol. 160 (1998) 2089-2098
31. Lutz M.B., and Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 23 (2002) 445-449
32. Sonoda K.-H., et al. CD1 reactive NKT cells are required for development of systemic tolerance through an immune privileged site. J. Exp. Med. 190 (1999) 1215-1225
33. Sonoda K.H., and Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32 (2002) 848-857
34. Ashour H.M., and Niederkorn J.Y. Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation. J. Immunol. 176 (2006) 5950-5957
35. D'Orazio T.J., and Niederkorn J.Y. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 95 (1998) 47-55
36. Granstein R.D., et al. Aqueous humor contains transforming growth factor-β and a small (<3500 daltons) inhibitor of thymocyte proliferation. J. Immunol. 144 (1990) 3021-3027
37. Cousins S.W., et al. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr. Eye Res. 10 (1991) 287-297
38. Cousins S.W., et al. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2201-2211
39. Hara Y., et al. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye. J. Immunol. 149 (1992) 1531-1538
40. Lin H.H., et al. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J. Exp. Med. 201 (2005) 1615-1625
41. van den Berg T.K., and Kraal G. A function for the macrophage F4/80 molecule in tolerance induction. Trends Immunol. 26 (2005) 506-509
42. McKnight A.J., et al. Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family. J. Biol. Chem. 271 (1996) 486-489
43. McKnight A.J., and Gordon S. EGF-TM7: a novel subfamily of seven-transmembrane-region leukocyte cell-surface molecules. Immunol. Today 17 (1996) 283-287
44. Pierce K.L., et al. Signalling: seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3 (2002) 639-650
45. Schrantz N., et al. The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J. Exp. Med. 204 (2007) 841-852
46. Bendelac A., et al. The biology of NKT cells. Annu. Rev. Immunol. 25 (2007) 297-336
47. + T regulatory cells following antigen inoculation in an immune privileged site. J. Immunol. 171 (2003) 1266-1271
48. Sonoda K.H., et al. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166 (2001) 42-50
49. Sonoda K.H., et al. NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye. J. Immunol. 179 (2007) 2215-2222
50. Watte C.M., et al. Ly49 C/I-dependent NKT cell-derived IL-10 is required for corneal graft survival and peripheral tolerance. J. Leukoc. Biol. 83 (2008) 928-935
51. Ljunggren G.-H., and Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11 (1990) 237-244
52. Raulet D.H., et al. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155 (1997) 41-52
53. Anderson S.K., et al. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 181 (2001) 79-89
54. + cells. J. Immunol. 160 (1998) 1158-1165
55. + T lymphocytes directed by T-cell receptor type. Immunology 110 (2003) 313-321
56. Ikarashi Y., et al. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production. J. Exp. Med. 194 (2001) 1179-1186
57. Maeda M., et al. Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line. J. Immunol. 167 (2001) 4180-4186
58. + T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 110 (2003) 18-29
59. Skelsey M.E., et al. γδ T cells are needed for ocular immune privilege and corneal graft survival. J. Immunol. 166 (2001) 4327-4333
60. Xu, Y. and Kapp, J.A. (2000) γδ T cells are critical for the induction of ACAID. Investigative Ophthalmology and Visual Science Annual Meeting Ft. Lauderdale, FL, April 30 - May 5, 2000, Abstract Issue 41 (4), S117
61. Kapp J.A., et al. Gammadelta T cells play an essential role in several forms of tolerance. Immunol. Res. 29 (2004) 93-102
62. Kapp J.A., et al. gammadelta T-cell clones from intestinal intraepithelial lymphocytes inhibit development of CTL responses ex vivo. Immunology 111 (2004) 155-164
63. Locke N.R., et al. TCR gamma delta intraepithelial lymphocytes are required for self-tolerance. J. Immunol. 176 (2006) 6553-6559
64. Wilbanks G.A., and Streilein J.W. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 71 (1990) 383-389
65. Keino H., et al. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1047-1055
66. Meng Q., et al. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation. Invest. Ophthalmol. Vis. Sci. 47 (2006) 4444-4452
67. Keino H., et al. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1533-1542
68. Jiang L., et al. Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation. Mol. Vis. 13 (2007) 968-974
69. Yoshida M., et al. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3862-3870
70. Yoshida M., et al. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest. Ophthalmol. Vis. Sci. 41 (2000) 811-821
71. Streilein J.W., et al. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest. Ophthalmol. Vis. Sci. 37 (1996) 413-424
72. Taylor A.W., et al. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153 (1994) 1080-1086
73. Taylor A.W., et al. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 11 (1992) 1199-1206
74. Taylor A.W., and Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol. Cell Biol. 79 (2001) 358-367
75. Niederkorn J.Y., and Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2700-2707
76. Hara Y., et al. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. J. Immunol. 148 (1992) 1685-1692
77. Krause I., et al. Immunomodulation of experimental autoimmune diseases via oral tolerance. Crit. Rev. Immunol. 20 (2000) 1-16
78. Whitacre C.C., et al. Oral tolerance in experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 778 (1996) 217-227
79. Weiner H.L., et al. ORAL TOLERANCE:Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12 (1994) 809-837
80. Tomasi Jr. T.B. Oral tolerance. Transplantation 29 (1980) 353-356
81. Khoury S.J., et al. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176 (1992) 1355-1364
82. Kim H.J., et al. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells. Immunology 118 (2006) 101-111
83. Roelofs-Haarhuis K., et al. Oral tolerance to nickel requires CD4(+) invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J. Immunol. 173 (2004) 1043-1050
84. Margenthaler J.A., et al. CD1-dependent natural killer (NK1.1 +) T cells are required for oral and portal venous tolerance induction. J. Surg. Res. 104 (2002) 29-35
85. D'Orazio T.J., et al. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J. Immunol. 166 (2001) 26-32
86. Nowak M., et al. Oral nickel tolerance: Fas ligand-expressing invariant NK T cells promote tolerance induction by eliciting apoptotic death of antigen-carrying, effete B cells. J. Immunol. 176 (2006) 4581-4589
87. Naumov Y.N., et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13838-13843
88. De Smedt T., et al. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27 (1997) 1229-1235